Cargando…
P1540: COVID-19 INFECTION AMONG CAR-T CELL THERAPY RECIPIENTS: A SINGLE CENTER EXPERIENCE
Autores principales: | Din, Mohammad Ammad Ud, Oh, Nayeon, Baluch, Aliyah, Klinkova, Olga, Quilitz, Rod, Alsina, Melissa, Bejanyan, Nelli, Castaneda, Omar, Chavez, Julio, Elmariah, Hany, Freeman, Ciara, Hansen, Doris, Jain, Michael, Khimani, Farhad, Lazaryan, Aleksandr, Liu, Hien, Mishra, Asmita, Ochoa, Leonel, Perez, Lia, Pidala, Joseph, Shah, Bijal, Nishihori, Taiga, Locke, Frederick, Faramand, Rawan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429980/ http://dx.doi.org/10.1097/01.HS9.0000973036.97124.6c |
Ejemplares similares
-
Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2023) -
Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2022) -
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
por: Lazaryan, Aleksandr, et al.
Publicado: (2022) -
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
por: Logue, Jennifer M., et al.
Publicado: (2022) -
Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
por: Logue, Jennifer M., et al.
Publicado: (2020)